Age-Related Macular Degeneration: A Connection between Human Herpes Virus-6A-Induced CD46 Downregulation and Complement Activation?

Frontiers in Immunology
Walter Fierz

Abstract

Viruses are able to interfere with the immune system by docking to receptors on host cells that are important for proper functioning of the immune system. A well-known example is the human immunodeficiency virus that uses CD4 cell surface molecules to enter host lymphocytes and thereby deleteriously destroying the helper cell population of the immune system. A more complicated mechanism is seen in multiple sclerosis (MS) where human herpes virus-6A (HHV-6A) infects astrocytes by docking to the CD46 surface receptor. Such HHV-6A infection in the brain of MS patients has recently been postulated to enable Epstein-Barr virus (EBV) to transform latently infected B-lymphocytes in brain lesions leading to the well-known phenomenon of oligoclonal immunoglobulin production that is widely used in the diagnosis of MS. The cellular immune response to HHV-6A and EBV is one part of the pathogenic mechanisms in MS. A more subtle pathogenic mechanism can be seen in the downregulation of CD46 on astrocytes by the infecting HHV-6A. Since CD46 is central in regulating the complement system, a lack of CD46 can lead to hyperactivation of the complement system. In fact, activation of the complement system in brain lesions is a well-known pathogenic...Continue Reading

References

Feb 1, 1996·Journal of Virology·J HeC Wood
Apr 1, 1996·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·K K Knox, D R Carrigan
Jun 17, 1998·Cellular Immunology·I J CraneJ V Forrester
Jan 5, 2000·Cell·F SantoroP Lusso
Feb 29, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·R S MilneU A Gompels
May 17, 2000·The Journal of General Virology·J Schneider-Schaulies
May 18, 2000·Reviews in Medical Virology·D A Clark
May 2, 2003·The Journal of Biological Chemistry·Fabio SantoroEdward A Berger
Jul 29, 2003·Investigative Ophthalmology & Visual Science·Barbara J McLaughlinHenry J Kaplan
Jun 23, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jingsheng TuoChi-Chao Chan
Mar 12, 2005·Science·Jonathan L HainesMargaret A Pericak-Vance
Mar 12, 2005·Science·Albert O EdwardsLindsay A Farrer
Mar 12, 2005·Science·Robert J KleinJosephine Hoh
Sep 9, 2006·Virology·Simon Metz Pedersen, Per Höllsberg
Feb 6, 2007·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Paolo Lusso
Aug 19, 2007·American Journal of Ophthalmology·Robert B Nussenblatt, Frederick Ferris
Oct 3, 2007·The Journal of Clinical Investigation·Christophe CombadièreFlorian Sennlaub
Aug 8, 2008·European Journal of Human Genetics : EJHG·Jesen A FagernessJohanna M Seddon
Dec 2, 2008·Clinical and Experimental Immunology·G IngramB P Morgan
Mar 26, 2009·Journal of Medical Virology·Matthew BatesUrsula A Gompels
Oct 20, 2009·Cell Host & Microbe·Pierre-Emmanuel JoubertMathias Faure
Apr 1, 2010·Acta Ophthalmologica·Kai Kaarniranta
May 13, 2010·Virology Journal·Yuichi MurakamiMasaki Yasukawa
Dec 21, 2011·Advances in Experimental Medicine and Biology·Sayak K MitterMichael E Boulton
May 15, 2012·Current Eye Research·Samantha BromfieldGerald McGwin
Jul 17, 2012·Neuron·Jayakrishna Ambati, Benjamin J Fowler
Nov 8, 2012·Advances in Virology·Takahiro Maeki, Yasuko Mori
Feb 9, 2013·JAMA Ophthalmology·Vinod P MittaDebra A Schaumberg
Aug 13, 2013·Progress in Retinal and Eye Research·Daniel Ardeljan, Chi-Chao Chan
Oct 29, 2013·Future Virology·Lorenzo DagnaPaolo Lusso
Nov 7, 2013·Archives of Virology·Dharam AblashiTetsushi Yoshikawa
Nov 10, 2013·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Carla Enrica GallengaPier Enrico Gallenga
Dec 27, 2013·Mediators of Inflammation·Francesco ParmeggianiMichele Rubini
Apr 30, 2014·Annual Review of Genomics and Human Genetics·Lars G FritscheAnand Swaroop
May 17, 2014·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Claudio Franceschi, Judith Campisi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.